The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor practice patterns, counsel individual patients, and determine the best candidates for lung transplantation. The authors used information from the Cystic Fibrosis Foundation Patient Registry (CFFPR), which has collected longitudinal data on approximately 90 % of cystic fibrosis patients diagnosed in the United States since 1986. They developed multivariate logistic regression models by using data on 5,820 patients randomly selected from 11,630 in the CFFPR in 1993. Models were tested for goodness ...
Thesis (Master's)--University of Washington, 2016-12Background Lung transplantation (LTx) is frequen...
Background: Lumacaftor/ivacaftor combination therapy is efficacious and generally safe for patients ...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
The objective of this study was to create a 5-year survivorship model to identify key clinical featu...
We evaluated a multivariable logistic regression model predicting 5-year survival derived from a 199...
Journal ArticleLung transplantation in cystic fibrosis may improve survival for patients with low 5-...
Lung transplantation in cystic fibrosis may improve survival for patients with low 5-year predicted ...
BACKGROUND: In 2001 Liou published a 5-year survival model using CFF Registry data. AIMS: To evaluat...
BACKGROUND: Cystic fibrosis (CF) is an inherited, chronic, progressive condition affecting around 10...
Background: In 2001 Liou published a 5-year survival model using CFF Registry data. Aims: To evaluat...
AbstractBackgroundIn 2001 Liou published a 5-year survival model using CFF Registry data.AimsTo eval...
Background For people with advanced stage cystic fibrosis (CF), tailored survival estimates could fa...
Journal ArticleLung transplantation is the most aggressive therapy available for end-stage lung dise...
Cystic fibrosis is an inherited disorder of the cystic fibrosis transmembrane conductance regulator ...
Background: Approximately 5-10% of cystic fibrosis (CF) diagnoses are made during adulthood. These p...
Thesis (Master's)--University of Washington, 2016-12Background Lung transplantation (LTx) is frequen...
Background: Lumacaftor/ivacaftor combination therapy is efficacious and generally safe for patients ...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
The objective of this study was to create a 5-year survivorship model to identify key clinical featu...
We evaluated a multivariable logistic regression model predicting 5-year survival derived from a 199...
Journal ArticleLung transplantation in cystic fibrosis may improve survival for patients with low 5-...
Lung transplantation in cystic fibrosis may improve survival for patients with low 5-year predicted ...
BACKGROUND: In 2001 Liou published a 5-year survival model using CFF Registry data. AIMS: To evaluat...
BACKGROUND: Cystic fibrosis (CF) is an inherited, chronic, progressive condition affecting around 10...
Background: In 2001 Liou published a 5-year survival model using CFF Registry data. Aims: To evaluat...
AbstractBackgroundIn 2001 Liou published a 5-year survival model using CFF Registry data.AimsTo eval...
Background For people with advanced stage cystic fibrosis (CF), tailored survival estimates could fa...
Journal ArticleLung transplantation is the most aggressive therapy available for end-stage lung dise...
Cystic fibrosis is an inherited disorder of the cystic fibrosis transmembrane conductance regulator ...
Background: Approximately 5-10% of cystic fibrosis (CF) diagnoses are made during adulthood. These p...
Thesis (Master's)--University of Washington, 2016-12Background Lung transplantation (LTx) is frequen...
Background: Lumacaftor/ivacaftor combination therapy is efficacious and generally safe for patients ...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...